𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel

✍ Scribed by Giuliana Cassinelli; Rosanna Supino; Valentina Zuco; Cinzia Lanzi; A.Ivana Scovassi; Sean C Semple; Franco Zunino


Book ID
113487282
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
356 KB
Volume
68
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of paclitaxel, estramusti
✍ David C. Smith; Christopher H. Chay; Rodney L. Dunn; Jude Fardig; Peg Esper; Kar πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Preclinical data suggest that the combination of intravenous (i.v.) paclitaxel, carboplatin, oral etoposide, and oral estramustine (TEEC) has significant activity in patients with advanced, hormone‐refractory prostate carcinoma. The authors conducted this clinical trial t

Role of diacylglycerol (DAG) in hormonal
✍ Olav F. Dajani; Dagny Sandnes; Øyvind Melien; Firous Rezvani; Laila S. Nilssen; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 261 KB πŸ‘ 3 views

The role of diacylglycerol (DAG) in hormonal induction of S phase was investigated in primary cultures of rat hepatocytes. In this model, several agonists that bind to G protein-coupled receptors act as comitogens when added to the cells soon after plating (i.e., in Go/early Gl phase), while the cel